• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Recordati Announce Publication of Outcomes From PIII LINC 3 Study of Isturisa

    BUSINESSWIRE

    Phase III LINC 3 Study Says ISTURISA Shows Improvement in Cushing’s Disease

    BUSINESSWIRE

    Recordati: Positive Results From the PH III LINC-3 Study of Isturisa®

    BUSINESSWIRE

    Recordati Rare Diseases: Isturisa® (osilodrostat) Phase III LINC-4 Trial

    BUSINESSWIRE

    Recordati Rare Diseases now holds Isturisa® European MA

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.